London - Imperial College
Imperial College ECMC aims to develop novel imaging, biomarker and therapeutic approaches for cancer, with a particular focus on reversing drug resistance and aiding personalised treatments. Other areas of expertise include metabolomics and epigenetics. Tissue banking (particularly lung and ovarian cancer samples) is also conducted to underpin the Centre’s biomarker research.
Clinical Focus Area
- Medical Oncology (With major focus on breast and ovarian cancers)
- Surgical Oncology
Scientific Focus Area
- Mechanisms of resistance to therapy; Imaging and biomarkers (genomics/epigenomics/CTC/IHC)
Disease Focus Area
| Breast | Colorectal | Leukaemia | Lung |
| Ovarian | Prostate |
Goals
For further information on the goals and objectives of Imperial College ECMC go to:
Skills
Imperial College ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Imperial College ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page